🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cutaneous lupus erythematosus (CLE) is an autoimmune disease of which the p...
Status
Unknown
Location
Centre for Human Drug Research
Start Date
2024-06
Trial ID
NCT06411106
Treatments Being Tested
Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outc...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00859105
Treatments Being Tested
The purpose of this study is to evaluate the performance of two techniques ...
Status
Completed
Location
Hopital L'Archet 2
Start Date
2006-02
Trial ID
NCT00294320
Treatments Being Tested
The purpose of this study is to investigate if imiquimod can be used as a n...
Status
Unknown
Location
Erasmus Medical center
Start Date
2016-05
Trial ID
NCT02669459
To evaluate the efficacy (defined as complete clinical response at 6 months...
Status
Completed
Location
Dep. of Gynecology, Krankenhaus Barmherzige Brüder Graz
Start Date
2013-06
Trial ID
NCT01861535
Cutaneous leishmaniasis is endemic in the New World from approximately the ...
Status
Completed
Location
Cenetrop
Start Date
2008-03
Trial ID
NCT01380314
Treatments Being Tested
This study will assess the coadministration of genetically attenuated Plasm...
Status
Unknown
Location
Leiden University Medical Center
Start Date
2023-02-03
Trial ID
NCT05468606
Treatments Being Tested
Despite the WHO International Health Regulations Emergency Committee declar...
Status
Completed
Location
The University of Hong Kong, Queen Mary Hospital
Start Date
2012-01
Trial ID
NCT01508884
Treatments Being Tested
To determine the comparability of the safety and efficacy of Imiquimod Crea...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2012-09
Trial ID
NCT01686152
Treatments Being Tested
This is a pilot/feasibility study. The study design represents a modificati...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-07-17
Trial ID
NCT01400672
Treatments Being Tested